SSG Capital Advises Unilife in Sale of Assets to UNL Holdings

SSG Capital Advisors acted as the investment banker to Unilife in the sale of substantially all of its assets to UNL Holdings, an affiliate of OrbiMed Advisors and Amgen.

OrbiMed Provides $100MM Natera Facility

Natera, a provider of non-invasive genetic testing and analysis of circulating cell-free DNA, entered into a $100 million credit agreement with OrbiMed Royalty Opportunities II as the lender.

OrbiMed Provides $100MM Facility to Pharming Group

Dutch pharmaceutical firm Pharming Group replaced its $100 million bridge finance with a $100 million permanent facility agreement. OrbiMed provided both financings.

Orbimed Advisors Supports $100MM Pharming Group Refi

Pharming Group completed a new $100 million finance agreement with Orbimed Advisors.

Xtant Medical Gets OrbiMed Financing; Engages Aurora Management

Xtant Medical Holdings entered into an amendment to its credit facility with OrbiMed Advisors for up to $15 million in financing to payoff SVB and for working capital.

OrbiMed to Provide $7MM DIP to Unilife

Unilife has secured $7 million debtor-in-possession financing from OrbiMed Advisors as part of its restructuring process via a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code.

MTS Securities Advises Iroko Pharmaceuticals on $75MM Facility

Iroko Pharmaceuticals announced it entered into a $75 million facility with an OrbiMed Advisors affiliate to support operations and its ZORVOLEX™ launch. MTS Securities acted as financial advisor.